China Resources Double-Crane Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000Q94
CNY
18.87
0.12 (0.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
2,627.69
3,038.07
2,628.69
2,584.87
3,052.52
3,106.46
2,584.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,627.69
3,038.07
2,628.69
2,584.87
3,052.52
3,106.46
2,584.69
Raw Material Cost
1,159.48
1,281.90
1,338.15
1,187.61
1,309.86
1,308.93
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.31
8.61
5.68
3.13
3.39
3.42
0.00
Selling and Distribution Expenses
849.68
1,068.47
991.73
880.46
1,059.80
1,113.12
0.00
Other Expenses
9.54
9.44
7.68
14.09
15.16
15.28
0.00
Total Expenditure (Excl Depreciation)
2,112.87
2,453.38
2,412.37
2,212.11
2,524.65
2,578.29
0.00
Operating Profit (PBDIT) excl Other Income
514.8
584.7
216.29999999999998
372.8
527.9
528.2
2584.7000000000003
Other Income
46.90
55.26
101.91
80.50
145.41
50.91
0.00
Operating Profit (PBDIT)
744.60
833.33
451.23
615.93
888.44
582.55
0.00
Interest
8.31
8.61
5.68
3.13
3.39
3.42
0.00
Exceptional Items
2.02
0.00
-31.05
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,468.22
1,756.17
1,290.55
1,397.27
1,742.67
1,797.54
0.00
Depreciation
193.54
193.54
193.39
193.39
184.76
0.00
0.00
Profit Before Tax
544.78
631.18
221.11
419.41
700.29
579.13
0.00
Tax
76.55
133.48
10.36
61.19
38.69
118.19
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
468.82
506.67
230.65
350.53
630.43
513.13
250.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
468.82
506.67
230.65
350.53
630.43
513.13
250.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
20.94
16.05
8.33
7.69
18.40
-11.13
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
489.76
522.73
238.98
358.23
648.83
502.00
250.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
11,041.03
10,919.69
10,407.86
10,193.71
9,934.14
10,407.86
11,090.41
Earnings per share (EPS)
0.45
0.49
0.22
0.34
0.61
0.49
0.26
Diluted Earnings per share
0.45
0.49
0.22
0.34
0.61
0.49
0.26
Operating Profit Margin (Excl OI)
19.19%
19.24%
5.93%
13.23%
18.29%
17.11%
0.0%
Gross Profit Margin
28.1%
27.15%
15.77%
23.71%
28.99%
18.64%
0.0%
PAT Margin
17.84%
16.68%
8.77%
13.56%
20.65%
16.52%
9.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is -13.92% vs 24.09% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is -24.51% vs 60.36% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is -6.10% vs 34.55% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 144.12% vs -20.93% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of China Resources Double-Crane Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,627.69
0
2,627.69
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,627.69
0
2,627.69
Raw Material Cost
1,159.48
0
1,159.48
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.31
0
8.31
Selling and Distribution Expenses
849.68
0
849.68
Other Expenses
9.54
0.00
9.54
Total Expenditure (Excl Depreciation)
2,112.87
0
2,112.87
Operating Profit (PBDIT) excl Other Income
514.82
0.00
514.82
Other Income
46.90
0
46.90
Operating Profit (PBDIT)
744.60
0
744.60
Interest
8.31
0
8.31
Exceptional Items
2.02
0
2.02
Gross Profit (PBDT)
1,468.22
0
1,468.22
Depreciation
193.54
0
193.54
Profit Before Tax
544.78
0
544.78
Tax
76.55
0
76.55
Provisions and contingencies
0
0
0.00
Profit After Tax
468.82
0
468.82
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
468.82
0
468.82
Share in Profit of Associates
0
0
0.00
Minority Interest
20.94
0
20.94
Other related items
0.00
0.00
0.00
Consolidated Net Profit
489.76
0
489.76
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,041.03
0
11,041.03
Earnings per share (EPS)
0.45
0
0.45
Diluted Earnings per share
0.45
0
0.45
Operating Profit Margin (Excl OI)
19.19%
0%
0.00
19.19%
Gross Profit Margin
28.10%
0%
0.00
28.10%
PAT Margin
17.84%
0%
0.00
17.84%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 262.77 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -13.51% vs 15.57% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -13.92% vs 24.09% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 48.98 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -6.29% vs 118.70% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -24.51% vs 60.36% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 69.77 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -10.33% vs 122.76% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -6.10% vs 34.55% in Jun 2024

Quarterly - Interest
Interest 0.83 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -3.49% vs 50.88% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 144.12% vs -20.93% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.19%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024